Inhibitor of differentiation 3 confers the robust anti-tumor activity of Kupffer cells

Jiang Ren; Sijia Liu; Long Zhang

doi:10.1002/mco2.708

MedComm ›› 2024, Vol. 5 ›› Issue (9) : e708 DOI: 10.1002/mco2.708

HIGHLIGHT

Inhibitor of differentiation 3 confers the robust anti-tumor activity of Kupffer cells

Jiang Ren ¹
, Sijia Liu ²
, Long Zhang ¹^,²^,³^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Jiang Ren, Sijia Liu, Long Zhang. Inhibitor of differentiation 3 confers the robust anti-tumor activity of Kupffer cells. MedComm, 2024, 5(9): e708 DOI:10.1002/mco2.708

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Deng Z, Loyher P-L, Lazarov T, et al. The nuclear factor ID3 endows macrophages with a potent anti-tumour activity. Nature. 2024; 626(8000): 864-873.

[2]	Pathria P, Louis TL, Varner JA. Targeting tumor-associated macrophages in cancer. Trends Immunol. 2019; 40(4): 310-327.

[3]	Mass E, Ballesteros I, Farlik M, et al. Specification of tissue-resident macrophages during organogenesis. Science. 2016; 353(6304): aaf4238.

[4]	Logtenberg MEW, Scheeren FA, Schumacher TN. The CD47-SIRPα immune checkpoint. Immunity. 2020; 52(5): 742-752.

[5]	Wattenberg MM, Coho H, Herrera VM, et al. Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1. Sci Immunol. 2023; 8(89): eadj5097.

RIGHTS & PERMISSIONS

2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.